APO Research
Talk to an analyst

APO RESEARCH · REPORT

Canagliflozin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Canagliflozin Industry Growth and Trends Forecast to 2032

19 December 202577 pages

Choose your research edition.

Industry ResearchCanagliflozin Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Canagliflozin Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Canagliflozin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Canagliflozin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Canagliflozin Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Canagliflozin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Canagliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Canagliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Canagliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Canagliflozin include Hansoh Pharma, Mitsubishi Tanabe Pharma, Hinye and Janssen Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Canagliflozin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Canagliflozin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Canagliflozin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Canagliflozin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Canagliflozin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Canagliflozin Market by Company

Hansoh Pharma

Mitsubishi Tanabe Pharma

Hinye

Janssen Pharmaceuticals

Canagliflozin Segment by Type

100mg

300mg

Canagliflozin Segment by Application

Diabetes

Heart Disease

Others

Canagliflozin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canagliflozin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Canagliflozin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canagliflozin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Canagliflozin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Canagliflozin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100mg Table 2. Major Company of 300mg Table 3. Global Canagliflozin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Canagliflozin Sales by Type (2021-2026) & (K Units) Table 5. Global Canagliflozin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Canagliflozin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Canagliflozin Sales Market Share in Value by Type (2021-2026) Table 8. Global Canagliflozin Price by Type (2021-2026) & (US$/Unit) Table 9. Global Canagliflozin Sales by Type (2027-2032) & (K Units) Table 10. Global Canagliflozin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Canagliflozin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Canagliflozin Sales Market Share in Value by Type (2027-2032) Table 13. Global Canagliflozin Price by Type (2027-2032) & (US$/Unit) Table 14. North America Canagliflozin Sales by Type (2021-2026) & (K Units) Table 15. North America Canagliflozin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Canagliflozin Sales by Type (2021-2026) & (K Units) Table 17. Europe Canagliflozin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Canagliflozin Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Canagliflozin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Canagliflozin Sales by Type (2021-2026) & (K Units) Table 21. Latin America Canagliflozin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Canagliflozin Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Canagliflozin Sales by Type (2021-2026) & (US$ Million) Table 24. Canagliflozin Industry Trends Table 25. Canagliflozin Industry Drivers Table 26. Canagliflozin Industry Opportunities and Challenges Table 27. Canagliflozin Industry Restraints Table 28. Global Canagliflozin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Canagliflozin Revenue Market Share by Company (2021-2026) Table 30. Global Canagliflozin Sales by Company (2021-2026) & (K Units) Table 31. Global Canagliflozin Sales Share by Company (2021-2026) Table 32. Global Canagliflozin Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Canagliflozin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Canagliflozin Major Company Production Sites and Headquarters Table 35. Global Canagliflozin Company, Product Type & Application Table 36. Global Canagliflozin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Canagliflozin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Canagliflozin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Canagliflozin Sales by Region (2021-2026) & (K Units) Table 41. Global Canagliflozin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Canagliflozin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Canagliflozin Sales Market Share in Value by Region (2021-2026) Table 44. Global Canagliflozin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Canagliflozin Sales by Region (2027-2032) & (K Units) Table 46. Global Canagliflozin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Canagliflozin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Canagliflozin Sales Market Share in Value by Region (2027-2032) Table 49. Global Canagliflozin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Canagliflozin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Canagliflozin Sales by Application (2021-2026) & (K Units) Table 52. Global Canagliflozin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Canagliflozin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Canagliflozin Sales Market Share in Value by Application (2021-2026) Table 55. Global Canagliflozin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Canagliflozin Sales by Application (2027-2032) & (K Units) Table 57. Global Canagliflozin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Canagliflozin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Canagliflozin Sales Market Share in Value by Application (2027-2032) Table 60. Global Canagliflozin Price by Application (2027-2032) & (US$/Unit) Table 61. North America Canagliflozin Sales by Application (2021-2026) & (K Units) Table 62. North America Canagliflozin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Canagliflozin Sales by Application (2021-2026) & (K Units) Table 64. Europe Canagliflozin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Canagliflozin Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Canagliflozin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Canagliflozin Sales by Application (2021-2026) & (K Units) Table 68. Latin America Canagliflozin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Canagliflozin Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Canagliflozin Sales by Application (2021-2026) & (US$ Million) Table 71. Hansoh Pharma Company Information Table 72. Hansoh Pharma Business Overview Table 73. Hansoh Pharma Canagliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Hansoh Pharma Canagliflozin Product Portfolio Table 75. Hansoh Pharma Recent Development Table 76. Mitsubishi Tanabe Pharma Company Information Table 77. Mitsubishi Tanabe Pharma Business Overview Table 78. Mitsubishi Tanabe Pharma Canagliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Mitsubishi Tanabe Pharma Canagliflozin Product Portfolio Table 80. Mitsubishi Tanabe Pharma Recent Development Table 81. Hinye Company Information Table 82. Hinye Business Overview Table 83. Hinye Canagliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hinye Canagliflozin Product Portfolio Table 85. Hinye Recent Development Table 86. Janssen Pharmaceuticals Company Information Table 87. Janssen Pharmaceuticals Business Overview Table 88. Janssen Pharmaceuticals Canagliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Janssen Pharmaceuticals Canagliflozin Product Portfolio Table 90. Janssen Pharmaceuticals Recent Development Table 91. North America Canagliflozin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. North America Canagliflozin Sales by Country (2021-2026) & (K Units) Table 93. North America Canagliflozin Sales Market Share by Country (2021-2026) Table 94. North America Canagliflozin Sales Forecast by Country (2027-2032) & (K Units) Table 95. North America Canagliflozin Sales Market Share Forecast by Country (2027-2032) Table 96. North America Canagliflozin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Canagliflozin Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Canagliflozin Market Share by Country (2021-2026) Table 99. North America Canagliflozin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Canagliflozin Market Share Forecast by Country (2027-2032) Table 101. Europe Canagliflozin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Europe Canagliflozin Sales by Country (2021-2026) & (K Units) Table 103. Europe Canagliflozin Sales Market Share by Country (2021-2026) Table 104. Europe Canagliflozin Sales Forecast by Country (2027-2032) & (K Units) Table 105. Europe Canagliflozin Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Canagliflozin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Canagliflozin Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Canagliflozin Market Share by Country (2021-2026) Table 109. Europe Canagliflozin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Canagliflozin Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Canagliflozin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Canagliflozin Sales by Country (2021-2026) & (K Units) Table 113. Asia-Pacific Canagliflozin Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Canagliflozin Sales Forecast by Country (2027-2032) & (K Units) Table 115. Asia-Pacific Canagliflozin Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Canagliflozin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Canagliflozin Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Canagliflozin Market Share by Country (2021-2026) Table 119. Asia-Pacific Canagliflozin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Canagliflozin Market Share Forecast by Country (2027-2032) Table 121. Latin America Canagliflozin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Latin America Canagliflozin Sales by Country (2021-2026) & (K Units) Table 123. Latin America Canagliflozin Sales Market Share by Country (2021-2026) Table 124. Latin America Canagliflozin Sales Forecast by Country (2027-2032) & (K Units) Table 125. Latin America Canagliflozin Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Canagliflozin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Canagliflozin Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Canagliflozin Market Share by Country (2021-2026) Table 129. Latin America Canagliflozin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Canagliflozin Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Canagliflozin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Canagliflozin Sales by Country (2021-2026) & (K Units) Table 133. Middle East and Africa Canagliflozin Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Canagliflozin Sales Forecast by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Canagliflozin Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Canagliflozin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Canagliflozin Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Canagliflozin Market Share by Country (2021-2026) Table 139. Middle East and Africa Canagliflozin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Canagliflozin Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Canagliflozin Distributors List Table 144. Canagliflozin Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Canagliflozin Image Figure 2. Global Canagliflozin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Canagliflozin Market Size (2021-2032) & (US$ Million) Figure 4. Global Canagliflozin Sales (2021-2032) & (K Units) Figure 5. 100mg Image Figure 6. Global 100mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 300mg Image Figure 8. Global 300mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Canagliflozin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Canagliflozin Market Share by Type 2025 VS 2032 Figure 11. North America Canagliflozin Sales Market Share in Volume by Type in 2025 Figure 12. North America Canagliflozin Sales Market Share in Value by Type in 2025 Figure 13. Europe Canagliflozin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Canagliflozin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Canagliflozin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Canagliflozin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Canagliflozin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Canagliflozin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Canagliflozin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Canagliflozin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Canagliflozin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Diabetes Image Figure 24. Global Diabetes Sales YoY Growth (2021-2032) & (K Units) Figure 25. Heart Disease Image Figure 26. Global Heart Disease Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Canagliflozin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Canagliflozin Market Share by Application 2025 VS 2032 Figure 31. North America Canagliflozin Sales Market Share in Volume by Application in 2025 Figure 32. North America Canagliflozin Sales Market Share in Value by Application in 2025 Figure 33. Europe Canagliflozin Sales Market Share in Volume by Application in 2025 Figure 34. Europe Canagliflozin Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Canagliflozin Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Canagliflozin Sales Market Share in Value by Application in 2025 Figure 37. Latin America Canagliflozin Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Canagliflozin Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Canagliflozin Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Canagliflozin Sales Market Share in Value by Application in 2025 Figure 41. North America Canagliflozin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Canagliflozin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Canagliflozin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Canagliflozin Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Canagliflozin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Canagliflozin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Canagliflozin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Canagliflozin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Canagliflozin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Canagliflozin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Canagliflozin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Canagliflozin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Canagliflozin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Canagliflozin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Canagliflozin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Canagliflozin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Canagliflozin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Canagliflozin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Canagliflozin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Canagliflozin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Canagliflozin Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Canagliflozin Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • 300mg
Applications
  • Diabetes
  • Heart Disease
  • Others
Companies covered
  • Hansoh Pharma
  • Mitsubishi Tanabe Pharma
  • Hinye
  • Janssen Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Canagliflozin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Canagliflozin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Canagliflozin Market by Type
  6. 1.3.1 100mg
  7. 1.3.2 300mg
  8. 1.4 Global Canagliflozin Market Size by Type
  9. 1.4.1 Global Canagliflozin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Canagliflozin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Canagliflozin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Canagliflozin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Canagliflozin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Canagliflozin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Canagliflozin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Canagliflozin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Canagliflozin Industry Trends
  2. 2.2 Canagliflozin Industry Drivers
  3. 2.3 Canagliflozin Industry Opportunities and Challenges
  4. 2.4 Canagliflozin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Canagliflozin Revenue (2021-2026)
  2. 3.2 Global Top Players by Canagliflozin Sales (2021-2026)
  3. 3.3 Global Top Players by Canagliflozin Price (2021-2026)
  4. 3.4 Global Canagliflozin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Canagliflozin Major Company Production Sites & Headquarters
  6. 3.6 Global Canagliflozin Company, Product Type & Application
  7. 3.7 Global Canagliflozin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Canagliflozin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Canagliflozin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Canagliflozin Tier 1, Tier 2, and Tier 3
4 Canagliflozin Regional Status and Outlook
  1. 4.1 Global Canagliflozin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Canagliflozin Historic Market Size by Region
  3. 4.2.1 Global Canagliflozin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Canagliflozin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Canagliflozin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Canagliflozin Forecasted Market Size by Region
  7. 4.3.1 Global Canagliflozin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Canagliflozin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Canagliflozin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Canagliflozin by Application
  1. 5.1 Canagliflozin Market by Application
  2. 5.1.1 Diabetes
  3. 5.1.2 Heart Disease
  4. 5.1.3 Others
  5. 5.2 Global Canagliflozin Market Size by Application
  6. 5.2.1 Global Canagliflozin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Canagliflozin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Canagliflozin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Canagliflozin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Canagliflozin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Canagliflozin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Canagliflozin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Canagliflozin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Hansoh Pharma
  2. 6.1.1 Hansoh Pharma Company Information
  3. 6.1.2 Hansoh Pharma Business Overview
  4. 6.1.3 Hansoh Pharma Canagliflozin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Hansoh Pharma Canagliflozin Product Portfolio
  6. 6.1.5 Hansoh Pharma Recent Developments
  7. 6.2 Mitsubishi Tanabe Pharma
  8. 6.2.1 Mitsubishi Tanabe Pharma Company Information
  9. 6.2.2 Mitsubishi Tanabe Pharma Business Overview
  10. 6.2.3 Mitsubishi Tanabe Pharma Canagliflozin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mitsubishi Tanabe Pharma Canagliflozin Product Portfolio
  12. 6.2.5 Mitsubishi Tanabe Pharma Recent Developments
  13. 6.3 Hinye
  14. 6.3.1 Hinye Company Information
  15. 6.3.2 Hinye Business Overview
  16. 6.3.3 Hinye Canagliflozin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hinye Canagliflozin Product Portfolio
  18. 6.3.5 Hinye Recent Developments
  19. 6.4 Janssen Pharmaceuticals
  20. 6.4.1 Janssen Pharmaceuticals Company Information
  21. 6.4.2 Janssen Pharmaceuticals Business Overview
  22. 6.4.3 Janssen Pharmaceuticals Canagliflozin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Janssen Pharmaceuticals Canagliflozin Product Portfolio
  24. 6.4.5 Janssen Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Canagliflozin Sales by Country
  2. 7.1.1 North America Canagliflozin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Canagliflozin Sales by Country (2021-2026)
  4. 7.1.3 North America Canagliflozin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Canagliflozin Market Size by Country
  6. 7.2.1 North America Canagliflozin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Canagliflozin Market Size by Country (2021-2026)
  8. 7.2.3 North America Canagliflozin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Canagliflozin Sales by Country
  2. 8.1.1 Europe Canagliflozin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Canagliflozin Sales by Country (2021-2026)
  4. 8.1.3 Europe Canagliflozin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Canagliflozin Market Size by Country
  6. 8.2.1 Europe Canagliflozin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Canagliflozin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Canagliflozin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Canagliflozin Sales by Country
  2. 9.1.1 Asia-Pacific Canagliflozin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Canagliflozin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Canagliflozin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Canagliflozin Market Size by Country
  6. 9.2.1 Asia-Pacific Canagliflozin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Canagliflozin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Canagliflozin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Canagliflozin Sales by Country
  2. 10.1.1 South America Canagliflozin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Canagliflozin Sales by Country (2021-2026)
  4. 10.1.3 South America Canagliflozin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Canagliflozin Market Size by Country
  6. 10.2.1 South America Canagliflozin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Canagliflozin Market Size by Country (2021-2026)
  8. 10.2.3 South America Canagliflozin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Canagliflozin Sales by Country
  2. 11.1.1 Middle East and Africa Canagliflozin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Canagliflozin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Canagliflozin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Canagliflozin Market Size by Country
  6. 11.2.1 Middle East and Africa Canagliflozin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Canagliflozin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Canagliflozin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Canagliflozin Value Chain Analysis
  2. 12.1.1 Canagliflozin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Canagliflozin Production Mode & Process
  7. 12.2 Canagliflozin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Canagliflozin Distributors
  10. 12.2.3 Canagliflozin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst